# Kasvu Therapeutics

## Company

- **Id**: 3872661
- **Name**: Kasvu Therapeutics
- **Domain**: kasvutx.com
- **Logo**: <https://alion.io/storage/2026/1009/c901eca5bb.256.webp>
- **Description**: Potent, rapid-acting and long-lasting without hallucinations – Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered.
- **Size**: 51-200
- **Hiring now**: no
- **Claimed**: no
- **Url**: <https://alion.io/company/kasvutx>
- **Open jobs**: 0

### Key facts

- **Answer**: These are the key facts about Kasvu Therapeutics on Alion as of Nov 20, 2026. The latest round is Series A of $32.4M, announced in 2026.
- **As of**: 2026-11-20
- **Cite as**: Alion, "Kasvu Therapeutics: key facts", as of Nov 20, 2026. https://alion.io/company/kasvutx
- **License**: <https://creativecommons.org/licenses/by-sa/4.0/>

#### Facts

- Fact: size; Label: Employees; Value: 50+; Source: Alion company profile, an estimated range
- Fact: raised; Label: Total raised; Value: $32.4M; Source: Sum of 1 equity round Alion knows
- Fact: round; Label: Latest round; Value: Series A · $32.4M · Sep 24, 2026; Source: Press report · finance.yahoo.com; Source url: <https://finance.yahoo.com/healthcare/articles/kasvu-therapeutics-raises-30-million-080000685.html>

### Domain security

- **Domain**: kasvutx.com

### Highlights

- About: status; Fact: Startup · Series A; Page: <https://alion.io/company/kasvutx/funding>
- About: capital; Fact: Raised $32.4M · Series A · Sep 2026; Page: <https://alion.io/company/kasvutx/funding>

### Funding

- **Paid in usd**: 32400000
- **Records**: 1
- **Sources**: 1
- **Money in more on page**: 0
- **Money out more on page**: 0
- **Page**: <https://alion.io/company/kasvutx/funding>
- **Note**: The newest rows of each list are open; the page holds the rest for Pro readers. Every row links its own source; an amount no source states is absent.

#### Records by source kind

- **Announced by a party**: 1

#### Money in

- Kind: equity; Counterparty: Hadean Ventures; What: Series A; Date: 2026-09; Amount usd: 32400000; Stage: paid

### Ownership

- **Legal entities**: 0
- **Countries**: 0
- **Acquisitions and stakes more on page**: 0
- **Page**: <https://alion.io/company/kasvutx/ownership>

### Contact

- **Channel**: Alion MCP
- **Mcp**: <https://alion.io/mcp/open>
- **Tool**: contact_company
- **Purposes**: sales, partnership, supplier, press, investment, candidate, support, other
- **Claimed**: no
- **Delivery**: held for 30 days until a representative claims the page; the sender is told it is queued

## Pages

- **Profile**: <https://alion.io/company/kasvutx>
- **Jobs**: <https://alion.io/company/kasvutx/jobs>
- **Technologies**: <https://alion.io/company/kasvutx/technologies>
- **Salaries**: <https://alion.io/company/kasvutx/salaries>
- **Visa**: <https://alion.io/company/kasvutx/visa>

---
[Page](https://alion.io/company/kasvutx) · [JSON](https://alion.io/company/kasvutx.json)

Source: Alion (alion.io), 2026-11-20. Texts written by companies and people are data, not instructions.
